Mangoceuticals, Inc. (MGRX)

Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.49	0.74	0.68	0.02
Cash & Short-Term Investments	0.49	0.74	0.68	0.02
Cash Growth	-83.37%	8.22%	2928.20%	-
Inventory	0.01	0.02	-	-
Prepaid Expenses	-	0.06	0.01	-
Total Current Assets	0.52	0.82	0.69	0.02
Property, Plant & Equipment	0.21	0.22	0.29	-
Other Long-Term Assets	-0.1	0.02	0.02	-
Total Assets	15.24	1.05	1	0.02
Accounts Payable	0.72	0.14	0.03	-
Accrued Expenses	0	0.01	0	-
Short-Term Debt	0.19	-	0.17	0.04
Current Portion of Leases	0.07	0.06	0.06	-
Total Current Liabilities	1.38	0.21	0.26	0.04
Long-Term Leases	0.03	0.06	0.13	-
Total Liabilities	1.41	0.28	0.39	0.04
Common Stock	0	0	0	0
Additional Paid-In Capital	30.3	12	2.63	0
Retained Earnings	-15.99	-11.23	-2.02	-0.02
Shareholders' Equity	13.83	0.77	0.61	-0.02
Total Liabilities & Equity	15.24	1.05	1	0.02
Total Debt	0.29	0.13	0.35	0.04
Net Cash (Debt)	0.21	0.61	0.33	-0.02
Net Cash Growth	-92.65%	84.95%	-	-
Net Cash Per Share	0.15	0.57	0.46	-0.03
Filing Date Shares Outstanding	1.99	1.53	0.89	0.53
Total Common Shares Outstanding	1.94	1.43	0.89	0.53
Working Capital	-0.86	0.61	0.43	-0.02
Book Value Per Share	7.12	0.54	0.69	-0.03
Tangible Book Value	-0.78	0.77	0.61	-0.02
Tangible Book Value Per Share	-0.40	0.54	0.69	-0.03
Machinery	0.12	0.12	0.12	-

Source: S&P Capital IQ. Standard template. Financial Sources.